Cannabidiol Market Trends

  • Report ID: 6084
  • Published Date: May 10, 2025
  • Report Format: PDF, PPT

Cannabidiol (CBD) Sector: Growth Drivers and Challenges

Growth Drivers

  • Therapeutic Properties of CBD Oil
  • Advantages of Cannabidiol in Treating Depression, Anxiety, Cancer, Diabetes, and Other Diseases
  • Rising R&D Activities About Benefits of CBD Oil

Challenges

  • Ban on Use of Cannabis Products in Many Countries

  • Lack of Awareness among People Regarding the Medical Advantages of CBD Oil

 


Base Year

2024

Forecast Year

2025-2037

CAGR

15.7%

Base Year Market Size (2024)

USD 9.27 billion

Forecast Year Market Size (2037)

USD 61.72 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Cannabidiol Market in 2025 is estimated at USD 10.43 billion.

The global market size was valued at over USD 9.27 billion in 2024 and is expected to expand at a CAGR of around 15.7%, surpassing USD 61.72 billion revenue by 2037.

North America is poised to hit USD 21.6 billion by 2037, driven by health-awareness, the acceptance of cannabis-based products, and research on cannabinoids.

The major players in the market include Medical Marijuana Inc., Cannoid, LLC, Isodiol International Inc., ENDOCA, Folium Biosciences, Aurora Cannabis Inc., Elixinol Global, CV Sciences, Medterra CBD, PharmaHemp.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos